FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Doctor, Staff Charged with Falsifying Trial Data

The Department of Justice says a federal grand jury has indicted the co-owner of Floridas Pine Care Research Center and two staff members on charges t...

latest-news-card-1
Medical Devices

Risk Management an Ever-Evolving Responsibility: Thomas

CDRH associate director for compliance and quality Keisha Thomas tells the RAPS Quality Conference about FDAs new Quality Management System Regulation...

latest-news-card-1
FDA General

17 Senate Democrats Hit HHS on FDA, Other Changes

Some 17 Senate Democrats write to HHS secretary Robert F. Kennedy Jr., questioning many of his personnel decisions and expressing concern about the na...

latest-news-card-1
Human Drugs

Zasocitinib Beats Sotyktu in Head-to-Head Study: Takeda

Takeda says its investigational TYK2 inhibitor zasocitinib performed significantly better than Bristol Myers Squibbs Sotyktu in a Phase 3 head-to-head...

latest-news-card-1
Human Drugs

CGMP Violations Seen in Port Jervis Records Review

FDA cautions Port Jervis Laboratories in Port Jervis, NY, about CGMP violations in its manufacturing of over-the-counter drugs.

latest-news-card-1
Human Drugs

Congressional Report Outlines FDA Oversight of AI-Enabled Devices

A new Congressional Research Service report outlines FDAs evolving approach to regulating artificial intelligence-enabled medical devices and reviews ...

latest-news-card-1
Medical Devices

Early Alert on Baxter Volara Breathing Device Circuits

FDA issues an early alert regarding a potentially high-risk issue affecting certain patient circuits used with Baxter's Volara System.

Animal Drugs

FDA Authorizes 1st Generic Animal Drug for New World Screwworm

FDA authorizes Felix Pharmaceuticals generic nitenpyram tablets to treat New World screwworm infestations in dogs and cats.

latest-news-card-1
Human Drugs

FDA Issues 2nd Complete Response Letter on Acromegaly Drug

FDA sends a second complete response letter to Camurus regarding its NDA for Oclaiz (octreotide), an extended-release injection under review for the t...

latest-news-card-1
Human Drugs

Kidney Risk in OTC Weight Loss Drug Alli

FDA approves labeling changes for Haleons OTC weight loss drug alli to warn of the rare risk of kidney injury associated with its use.